Home | Business News | Browse by Publication | P | PR Newswire

Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development.

Publication: PR Newswire
Publication Date: 21-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
The World's Most Prevalent Sexually-Transmitted Bacteria Phase II STTR from the National Institute of Allergy and Infectious Diseases

IRVINE, Calif., Sept. 21 /PRNewswire/ -- Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Bravado Partners With First Commemorative Mint for Official Michael Ja..., September 21, 2009
Everclear Returns With New Album & Tour!, September 21, 2009
Netlist Receives NASDAQ Notification Related to Minimum Bid Price., September 21, 2009
Six-time Academy Award(R) Winning Special Makeup Effects Artist, Rick ..., September 21, 2009
Macerich Announces Pay Off of $446 Million of 2010 Term Notes., September 21, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.